297 related articles for article (PubMed ID: 24307574)
1. Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.
Ni Z; Knorr DA; Bendzick L; Allred J; Kaufman DS
Stem Cells; 2014 Apr; 32(4):1021-31. PubMed ID: 24307574
[TBL] [Abstract][Full Text] [Related]
2. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.
Ni Z; Knorr DA; Clouser CL; Hexum MK; Southern P; Mansky LM; Park IH; Kaufman DS
J Virol; 2011 Jan; 85(1):43-50. PubMed ID: 20962093
[TBL] [Abstract][Full Text] [Related]
3. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
Zhu H; Kaufman DS
Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
[TBL] [Abstract][Full Text] [Related]
4. Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains.
Lin WY; Roberts MR
Blood; 2002 Oct; 100(8):3045-8. PubMed ID: 12351421
[TBL] [Abstract][Full Text] [Related]
5. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
Li Y; Hermanson DL; Moriarity BS; Kaufman DS
Cell Stem Cell; 2018 Aug; 23(2):181-192.e5. PubMed ID: 30082067
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.
Kamata M; Kim PY; Ng HL; Ringpis GE; Kranz E; Chan J; O'Connor S; Yang OO; Chen IS
Biochem Biophys Res Commun; 2015 Jul; 463(3):216-21. PubMed ID: 25998390
[TBL] [Abstract][Full Text] [Related]
7. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.
Knorr DA; Ni Z; Hermanson D; Hexum MK; Bendzick L; Cooper LJ; Lee DA; Kaufman DS
Stem Cells Transl Med; 2013 Apr; 2(4):274-83. PubMed ID: 23515118
[TBL] [Abstract][Full Text] [Related]
8. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
Mitsuyasu RT; Anton PA; Deeks SG; Scadden DT; Connick E; Downs MT; Bakker A; Roberts MR; June CH; Jalali S; Lin AA; Pennathur-Das R; Hege KM
Blood; 2000 Aug; 96(3):785-93. PubMed ID: 10910888
[TBL] [Abstract][Full Text] [Related]
10. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
11. Development of innate immune cells from human pluripotent stem cells.
Bernareggi D; Pouyanfard S; Kaufman DS
Exp Hematol; 2019 Mar; 71():13-23. PubMed ID: 30611869
[TBL] [Abstract][Full Text] [Related]
12. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.
Hermanson DL; Bendzick L; Pribyl L; McCullar V; Vogel RI; Miller JS; Geller MA; Kaufman DS
Stem Cells; 2016 Jan; 34(1):93-101. PubMed ID: 26503833
[TBL] [Abstract][Full Text] [Related]
13. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
[TBL] [Abstract][Full Text] [Related]
14. Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs).
Bock AM; Knorr D; Kaufman DS
J Vis Exp; 2013 Apr; (74):e50337. PubMed ID: 23644738
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
16. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
Deeks SG; Wagner B; Anton PA; Mitsuyasu RT; Scadden DT; Huang C; Macken C; Richman DD; Christopherson C; June CH; Lazar R; Broad DF; Jalali S; Hege KM
Mol Ther; 2002 Jun; 5(6):788-97. PubMed ID: 12027564
[TBL] [Abstract][Full Text] [Related]
17. Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.
Tang SY; Zha S; Du Z; Zeng J; Zhu D; Luo Y; Wang S
Stem Cell Res Ther; 2021 Nov; 12(1):580. PubMed ID: 34802459
[TBL] [Abstract][Full Text] [Related]
18. Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy.
Zhu H; Kaufman DS
Blood Sci; 2019 Aug; 1(1):4-11. PubMed ID: 35402797
[TBL] [Abstract][Full Text] [Related]
19. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
[TBL] [Abstract][Full Text] [Related]
20. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
Front Immunol; 2020; 11():561553. PubMed ID: 33178188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
